Point Of Care Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00006394
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 483
Buy Now

Point of Care Diagnostics Market Scope and Key Players 2031

Buy Now


Point of Care Diagnostics Market Report Scope

Report Attribute Details
Market size in 2024 US$ 37.93 Billion
Market Size by 2031 US$ 88.83 Billion
Global CAGR (2024 - 2031) 13.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Glucose Monitoring
  • Infectious Disease Testing
  • Cardiometabolic Testing
  • Pregnancy and Fertility Testing
  • Coagulation Testing
  • Tumor/Cancer Marker Testing
  • Cholesterol Testing
  • Urinalysis Testing
  • Hematology Testing
  • Thyroid Testing
By Purchase Mode
  • OTC
  • Prescription
By Sample
  • Blood
  • Urine
By End User
  • Healthcare Facilities
  • Homecare
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • F Hoffmann La Roche Ltd
  • Bio Rad Laboratories Inc
  • Abbott Laboratories
  • QIAGEN NV
  • Siemens AG
  • BD
  • bioMerieux SA
  • Polymer Technology Systems Inc PTS
  • Nova Biomedical Corporation